Stefanie Kraff

436 total citations
15 papers, 271 citations indexed

About

Stefanie Kraff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Stefanie Kraff has authored 15 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Stefanie Kraff's work include Cancer Treatment and Pharmacology (11 papers), Neutropenia and Cancer Infections (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Stefanie Kraff is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Neutropenia and Cancer Infections (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Stefanie Kraff collaborates with scholars based in Germany, Switzerland and Netherlands. Stefanie Kraff's co-authors include Ulrich Jaehde, Markus Joerger, Berta Moritz, Salvatore J. Salamone, Sigrun Unger, Kirstin Thelen, Ashraf Yassen, Stephan Schwers, Dirk Thomas and Sonja Schiffer and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Stefanie Kraff

14 papers receiving 268 citations

Peers

Countries citing papers authored by Stefanie Kraff

Since Specialization

Citations

This map shows the geographic impact of Stefanie Kraff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Kraff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Kraff more than expected).

Fields of papers citing papers by Stefanie Kraff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Kraff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Kraff. The network helps show where Stefanie Kraff may publish in the future.

Co-authorship network of co-authors of Stefanie Kraff

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Kraff. A scholar is included among the top collaborators of Stefanie Kraff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Kraff. Stefanie Kraff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics 2019 ·Research and Practice in Thrombosis and Haemostasis ·Dirk Thomas, Kirstin Thelen, Stefanie Kraff, Stephan Schwers, Sonja Schiffer, Sigrun Unger, Ashraf Yassen, (unknown)	58
2	Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia 2017 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Markus Joerger, Stefanie Kraff, Ulrich Jaehde, Wilhelm Huisinga, Charlotte Kloft, Zinnia P. Parra‐Guillén	19
3	Validation of a Commercial Assay and Decision Support Tool for Routine Paclitaxel Therapeutic Drug Monitoring (TDM) 2017 ·Therapeutic Drug Monitoring ·Markus Joerger, Stefanie Kraff, Ulrich Jaehde, Ralf A. Hilger, (unknown), Daniel J. Cline, Sonali P. Jog, Irina Baburina, Michael Craig Miller, Salvatore J. Salamone	13
4	Prospective, multi-center study of 5-fluorouracil (5-FU) therapeutic drug management (TDM) in metastatic colorectal cancer (mCRC) patients treated in routine clinical practice. 2017 ·Journal of Clinical Oncology ·Salvatore J. Salamone, Ulrich Jaehde, Lothar Mueller, (unknown), Stefan Holdenrieder, Thomas Bertsch, Yon‐Dschun Ko, Volker Kunzmann, (unknown), Jan Braess, Max Roessler, Berta Moritz, Stefanie Kraff, Michael Craig Miller, Martin Wilhelm	3
5	Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice 2016 ·Clinical Colorectal Cancer ·Martin Wilhelm, Lothar Mueller, Michael Craig Miller, (unknown), (unknown), Thomas Bertsch, Volker Kunzmann, Oliver J. Stoetzer, (unknown), Jan Braess, Josef Birkmann, Max Roessler, Berta Moritz, Stefanie Kraff, Salvatore J. Salamone, Ulrich Jaehde	54
6	Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced Non-Small Cell Lung Cancer (NSCLC) patient 2016 ·Pneumologie ·Joachim von Pawel, Stefanie Kraff, (unknown), Wilfried Eberhardt, Thomas Gauler, Lothar Müller, Niels Reinmuth, Martin Reck, Martin Kimmich, F. Mayer, H-G. Kopp, (unknown), (unknown), M. Frueh, (unknown), Max Roessler, Berta Moritz, Ulrich Jaehde, Markus Joerger	4
7	Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy 2015 ·Cancer Chemotherapy and Pharmacology ·Stefanie Kraff, Annemieke J.M. Nieuweboer, Ron H.J. Mathijssen, Florent Baty, (unknown), Ron H. N. van Schaik, Ulrich Jaehde, Markus Joerger	17
8	Excel-Based Tool for Pharmacokinetically Guided Dose Adjustment of Paclitaxel 2015 ·Therapeutic Drug Monitoring ·Stefanie Kraff, Andreas Lindauer, Markus Joerger, Salvatore J. Salamone, Ulrich Jaehde	19
9	A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens. 2015 ·Journal of Clinical Oncology ·Volker Kunzmann, (unknown), Michael Craig Miller, Stefan Holdenrieder, Thomas Bertsch, Lothar Mueller, Yon‐Dschun Ko, Oliver J. Stoetzer, (unknown), Jan Braess, Ulrich Jaehde, Max Roessler, Berta Moritz, Stefanie Kraff, (unknown), Salvatore J. Salamone, Martin Wilhelm	3
10	Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer (NSCLC) patient. 2015 ·Journal of Clinical Oncology ·Markus Joerger, Joachim von Pawel, Stefanie Kraff, (unknown), Wilfried Eberhardt, Thomas Gauler, Lothar Mueller, Niels Reinmuth, Martin Reck, Martin Kimmich, Frank Mayer, Hans‐Georg Kopp, Dirk Behringer, Yon‐Dschun Ko, M. Frueh, Ralf A. Hilger, Max Roessler, Berta Moritz, Ulrich Jaehde	3
11	Single-Dose Pharmacokinetics of Cidofovir in Continuous Venovenous Hemofiltration 2014 ·Antimicrobial Agents and Chemotherapy ·Matthias G. Vossen, (unknown), Walter Jäger, Stefanie Kraff, Florian Thalhammer	4
12	Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiafiltration in Critically Ill Patients 2013 ·Antimicrobial Agents and Chemotherapy ·Thomas Horvatits, Reinhard Kitzberger, Andreas Drolz, Christian Zauner, Walter Jäger, Michaela Böhmdorfer, Stefanie Kraff, (unknown), Florian Thalhammer, Valentin Fuhrmann, Peter Schenk	26
13	Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring 2012 ·Clinical Pharmacokinetics ·Markus Joerger, Stefanie Kraff, Alwin D. R. Huitema, Gary Feiss, Berta Moritz, Jan H.M. Schellens, Jos H. Beijnen, Ulrich Jaehde	46
14	Evaluation of a Pharmacology-Driven Dosing Algorithm of 3-Weekly Paclitaxel Using Therapeutic Drug Monitoring 2012 ·Clinical Pharmacokinetics ·Markus Joerger, Stefanie Kraff, Alwin D. R. Huitema, Gary Feiss, Berta Moritz, Jan H.M. Schellens, Jos H. Beijnen, Ulrich Jaehde	1
15	[Pharmaceutical care for a multimorbid patient mainly suffering from chronic obstructive pulmonary disease]. 2009 ·PubMed ·Stefanie Kraff, (unknown), (unknown), (unknown), U. Braun, (unknown), Ulrich Jaehde	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact